OSR HOLDINGS INC (OSRH) Stock Price, Forecast & Analysis
NASDAQ:OSRH • US68840D1028
OSRH Key Statistics, Chart & Performance
The current stock price of OSRH is 0.462 USD. In the past month the price decreased by -37.07%.
OSRH Technical Analysis
OSRH Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to OSRH. Both the profitability and financial health of OSRH have multiple concerns.
OSRH Financial Highlights
Over the last trailing twelve months OSRH reported a non-GAAP Earnings per Share(EPS) of -1.73. The EPS decreased by -253.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.58% | ||
| ROE | -18.56% | ||
| Debt/Equity | 0.05 |
OSRH Forecast & Estimates
7 analysts have analysed OSRH and the average price target is 10.2 USD. This implies a price increase of 2107.79% is expected in the next year compared to the current price of 0.462.
OSRH Ownership
OSRH Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.67 | 390.397B | ||
| AMGN | AMGEN INC | 16.25 | 197.396B | ||
| GILD | GILEAD SCIENCES INC | 17.02 | 193.298B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.81 | 117.026B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.87 | 81.87B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 46.05 | 42.576B | ||
| INSM | INSMED INC | N/A | 31.656B | ||
| NTRA | NATERA INC | N/A | 29.322B | ||
| BIIB | BIOGEN INC | 12.85 | 28.06B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.16 | 20.49B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OSRH
Company Profile
OSR Holdings, Inc. operates as a global healthcare company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.
Company Info
OSR HOLDINGS INC
10900 Ne 4Th Street, Suite 2300
Bellevue WASHINGTON US
Employees: 0
Phone: 14256357700
OSR HOLDINGS INC / OSRH FAQ
Can you describe the business of OSR HOLDINGS INC?
OSR Holdings, Inc. operates as a global healthcare company. The company is headquartered in Bellevue, Washington. The company went IPO on 2023-02-10. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.
What is the current price of OSRH stock?
The current stock price of OSRH is 0.462 USD. The price decreased by -4.15% in the last trading session.
What is the dividend status of OSR HOLDINGS INC?
OSRH does not pay a dividend.
What is the ChartMill technical and fundamental rating of OSRH stock?
OSRH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Is OSR HOLDINGS INC (OSRH) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OSRH.
What is OSR HOLDINGS INC worth?
OSR HOLDINGS INC (OSRH) has a market capitalization of 11.86M USD. This makes OSRH a Nano Cap stock.
What is the next earnings date for OSRH stock?
OSR HOLDINGS INC (OSRH) will report earnings on 2026-04-17.